Information  X 
Enter a valid email address

Faron Pharma OY Ord NPV (DI) (FARN)

Date Time Source Announcement
24 Sep 2020 7:15 am
RNS
Exercise of options
  7:00 am
RNS
Half-year Report
18 Sep 2020 7:00 am
RNS
MATINS trial data presented at ESMO
09 Sep 2020 12:00 pm
RNS
Faron to Present at H.C. Wainwright Conference
27 Aug 2020 7:00 am
RNS
Notice of Half-Year Report
18 Aug 2020 7:00 am
RNS
Traumakine Update
17 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
27 Jul 2020 7:00 am
RNS
Change of Adviser
20 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
08 Jul 2020 3:00 pm
RNS
Managers' transactions
16 Jun 2020 7:01 am
RNS
Faron hosts virtual R&D Day today
  7:00 am
RNS
Faron update on pipeline progress ahead of R&D Day
15 Jun 2020 7:00 am
RNS
Faron receives EUR 2.1 million funding from BF
11 Jun 2020 7:00 am
RNS
Faron selected for EUR2.5 million grant from EIC
01 Jun 2020 7:00 am
RNS
MATINS Update
28 May 2020 7:00 am
RNS
Faron announces R&D Day to be held in June
20 May 2020 7:00 am
RNS
Publication in Intensive Care Medicine
18 May 2020 4:00 pm
RNS
Results of the Annual General Meeting
13 May 2020 1:00 pm
RNS
Exercise of options
12 May 2020 6:00 pm
RNS
Managers' transactions
11 May 2020 10:00 am
RNS
Faron receives grant from Business Finland
05 May 2020 7:00 am
RNS
Clevegen manufacturing agreement
29 Apr 2020 1:15 pm
RNS
Holding(s) in Company
27 Apr 2020 2:45 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Traumakine to be a part of WHO's Solidarity trial
23 Apr 2020 1:00 pm
RNS
Update on results of Placing and issue of equity
22 Apr 2020 7:00 am
RNS
Result of placing and issue price
21 Apr 2020 4:45 pm
RNS
Proposed Placing
15 Apr 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
14 Apr 2020 7:00 am
RNS
Notice of Annual General Meeting
03 Apr 2020 2:45 pm
RNS
AGM to be postponed
01 Apr 2020 7:00 am
RNS
REMAP-CAP to study IFN beta-1a effect in COVID-19
30 Mar 2020 7:00 am
RNS
Part 1 of the MATINS Phase I/II Study Completed
26 Mar 2020 10:00 am
RNS
Correction to Faron?s Annual Report 2019
25 Mar 2020 7:28 am
RNS
Faron?s Annual Report 2019 published
20 Mar 2020 11:30 am
RNS
Notice of Annual General Meeting
  7:00 am
RNS
Final Results for the year ended December 31, 2019
19 Mar 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
12 Mar 2020 4:44 pm
RNS
Second Price Monitoring Extn
  4:38 pm
RNS
Price Monitoring Extension
09 Mar 2020 7:00 am
RNS
FDA accepts protocol for new Traumakine trial
05 Mar 2020 7:00 am
RNS
MATINS update
02 Mar 2020 7:00 am
RNS
Faron to acquire AOC3 antagonist platform
26 Feb 2020 7:05 am
RNS
Price Monitoring Extension
  7:01 am
RNS
Second Price Monitoring Extn
  7:00 am
RNS
Price Monitoring Extension
25 Feb 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:00 am
RNS
Price Monitoring Extension
24 Feb 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
18 Feb 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
06 Feb 2020 7:00 am
RNS
Traumakine update
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t